Amanda Kane, MD
Obstetrics & Gynecology · Clearwater, FLNPI 1215299540
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $9,312 with a category attached, or 64.4%. Distalmotion US accounts for 66.2% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $6,340 and has fallen 99.8% since, to $14 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $141.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Distalmotion US$6K
- Intuitive Surgical$2K
- Coloplast$292
- Astellas Pharma US Inc$253
- AbbVie$252
- Axonics, Inc.$225
- plus $588 from 22 others
What the payments were for
- Consulting fees$6,00064%
- Travel & lodging$4215%
- Food & beverage$1,29814%
- Education$1,59317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Distalmotion US | 2 | $6,168 |
| Intuitive Surgical | 3 | $1,534 |
| Coloplast | 4 | $292 |
| Astellas Pharma US Inc | 5 | $253 |
| AbbVie(2 entities) | 14 | $252 |
| Axonics, Inc. | 4 | $225 |
| Bayer | 4 | $68 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Duchesnay USA Incorporated | 2 | $44 |
| Amgen | 2 | $42 |
| Therapeuticsmd, Inc. | 3 | $39 |
| Baxter Healthcare | 1 | $34 |
| Myovant Sciences Inc. | 2 | $28 |
| Exeltis, USA Inc. | 2 | $27 |
| Convatec Inc. | 2 | $27 |
| Johnson & Johnson | 1 | $25 |
| Coopersurgical, Inc. | 1 | $25 |
| AMAG Pharmaceuticals, Inc. | 2 | $23 |
| Roche Diagnostics Corporation | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Pfizer | 1 | $19 |
| Caldera Medical, Inc | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
| Millicent US Inc | 1 | $12 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXTER L6 ROBOT$6,168
- DAVINCI XI$1,500
- ALTIS$253
- Veozah$125
- Axonics r-SNM System$101
How this compares
$9,312 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 27 | $28,080 |
| Estradiol | 445 | $23,094 |
| PremarinEstrogens, Conjugated | 16 | $8,354 |
| Clobetasol Propionate | 134 | $7,182 |
| YuvafemEstradiol | 38 | $6,384 |
| ProgesteroneProgesterone, Micronized | 191 | $5,791 |
| Estradiol (Twice Weekly)Estradiol | 47 | $4,688 |
| Oxybutynin Chloride ErOxybutynin Chloride | 74 | $2,206 |
| Estradiol (Once Weekly)Estradiol | 18 | $1,890 |
| ValacyclovirValacyclovir Hcl | 62 | $1,621 |
| Medroxyprogesterone Acetate | 39 | $840 |
| Triamcinolone Acetonide | 109 | $648 |
| Terconazole | 26 | $579 |
| Metronidazole | 23 | $372 |
| Fluconazole | 54 | $353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $253 | $28,08027 claims |
| PfizerPremarin | $19 | $8,35416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Clearwater
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.